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MenACWY conjugate vaccination was recently introduced 
in the United Kingdom for adolescents and young adults 
to reduce disease from infection by Neisseria meningitidis 
group W. We conducted a cross-sectional meningococcal 
carriage study in first-year UK university students. Despite 
71% MenACWY vaccine coverage, carriage of group W in-
creased substantially.
Neisseria meningitidis causes severe sepsis and men-ingitis. The main reservoir in most populations is as-
ymptomatic pharyngeal carriage in older adolescents and 
young adults (1). High carriage rates are particularly evi-
dent in semiclosed communities of young adults, such as 
university student populations, where persons live, work, 
and socialize together (2). 
Meningococcal carriage was previously assessed in 
university students in the United Kingdom during 2009–10 
at the University of Nottingham (UoN) when a high preva-
lence of capsular group Y (MenY) meningococcal carriage 
was detected (3). This high level of MenY carriage was 
concomitant with a rise in disease caused by MenY strains 
in the United Kingdom (4). Since 2009, although MenY 
disease has plateaued, capsular group W (MenW) disease 
has steadily increased because of the rapid expansion of hy-
pervirulent strains belonging to the sequence type 11 clonal 
complex (MenW:ST-11) (5). 
Analysis of whole-genome sequence data has shown 
that isolates from the same MenW:ST-11 lineage, termed 
the South American/UK strain, are also endemic to Chile, 
Brazil, and Argentina (6) and were recently reported in 
Australia (7). In response, Public Health England intro-
duced the MenACWY vaccine in the routine adolescent 
school program for 14- and 15-year-olds and first-year 
university students (8). A catch-up campaign was used to 
offer MenACWY vaccine to all 14–18-year-old persons, 
with persons who left school in 2015 (17–18 years of age) 
given priority.
The rationale for targeting the vaccine to older ad-
olescents and young adults stems from carriage studies 
showing that this demographic represents the principal 
reservoir of meningococcal carriage, as well as experi-
ence with other polysaccharide conjugate vaccines. In-
troduction of the MenC monovalent conjugate vaccines 
previously reduced carriage acquisition of MenC strains 
in adolescents and young adults (9). There is evidence, 
albeit limited, to suggest that the quadrivalent vaccine 
may have a similar effect on carriage of MenCWY strains 
(10,11). Reduced carriage in this population should lead 
to indirect protection of other age groups through herd 
immunity, thus enhancing the public health effect and 
cost-effectiveness of this approach.
The Study
To assess trends in meningococcal strain carriage, and to 
determine the immediate effect of the MenACWY vac-
cine on carriage of MenW/Y strains, we conducted a 
cross-sectional study in first-year students at the UoN from 
registration during September 2015 through March 2016. 
MenACWY vaccination coverage in this student popula-
tion increased from 31% (preregistration) to ≈70% (im-
mediately postregistration) as a result of a campus-based 
vaccination campaign targeting freshmen (12). 
The study was approved by the Research Ethics Com-
mittee at the UoN, and written informed consent was ob-
tained from all participants. We recruited convenience 
samples of first-year students in September and November 
2015 and March 2016. In September, students were recruit-
ed during registration; in November and March, students 
were recruited in 5 dormitories (A–E) with single-occupan-
cy rooms. We searched the UoN Health Service registra-
tion database (EMIS Web software; EMIS Health, Leeds, 
UK) to determine vaccination status in registered first-year 
students on arrival at the UoN and after the campus-based 
vaccination campaign.
In September, we obtained pharyngeal swab speci-
mens from eligible students immediately before they 
received the MenACWY vaccine. We immediately in-
oculated all pharyngeal swabs onto GC selective agar 
(Oxoid, Basingstoke, UK) and incubated them at 37°C 
in air containing 5% CO2. After 24 and 48 hours, we 
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selected oxidase-positive colonies suggestive of Neisseria 
spp. and confirmed their identity by amplification of the 
meningococcal gene crgA plus ctrA and/or porA, as de-
scribed previously (13).
We performed PCR-based genogrouping as described 
previously (13,14). The Meningococcal Reference Unit, 
Public Health England, Manchester, UK, performed sero-
grouping and serotyping of MenW isolates using dot-blot 
enzyme immunoassay. Sequence data derived from ampli-
fied porA and factor H–binding protein alleles was queried 
against the PubMLST/Neisseria database (http://pubmlst.
org/neisseria). We performed χ2 tests for significance by 
using STATCALC (Epi Info version 7.2.0.1; Centers for 
Disease Control and Prevention, Atlanta, GA, USA).
The September sample of 769 first-year students rep-
resented 10.9% of the 7,049 first-year students registered in 
2015. Carriage rates among this group increased from 14% 
in late September 2015 to 39% by mid-November 2015 and 
46% in March 2016 (online Technical Appendix Table 1, 
http://wwwnc.cdc.gov/EID/article/23/6/16-1768-Techapp1.
pdf). The characteristics of enrolled students and behavioral 
risk factors for carriage were similar at the 3 time points. The 
initial carriage rate of 14% was much lower for first-year 
students in September 2015 than in September 2009 (23.2%; 
χ2 = 34, df = 1; p<0.00001) (3), suggesting a reduction in me-
ningococcal carriage in adolescents in the United Kingdom, 
possibly attributable to an alteration in risk factors for car-
riage. The MenY carriage rate for incoming students (1.8%) 
was also lower than that detected in 2009 (2.9%; χ2 = 2.0, df 
= 1; p = 0.15) (3).
In September 2015, carriage rates were 4.2% for geno-
group capsule null locus (cnl), 3.3% for B, 1.8% for Y, 
and 0.7% for W strains. A substantial part of the increase 
in carriage from September 2015 through March 2016 was 
the result of a notable increase (0.7% to 8.0%) in carriage 
of MenW strains (online Technical Appendix Table 1). 
No change in the carriage of MenY strains was detected 
(online Technical Appendix Table 1). Of the 50 students 
colonized with MenW, 36 (72%) had received MenACWY 
vaccine either before or during registration, which is con-
sistent with the overall MenACWY coverage in our first-
year student cohort. Students colonized with MenW at the 
second and third sampling times were distributed across 
all 5 dormitories, suggesting widespread dissemination, 
and 21 (91%) of the MenW carriers in the last time point 
(March 2016) had been vaccinated at least 5 months before 
sampling (online Technical Appendix Table 2).
Analysis of the genogroup W isolates showed that 47 
(90%) of 52 were serotype 2a (online Technical Appendix 
Table 1) and harbored alleles for factor H binding protein 
peptide 22 and PorA P1.5,2, identical to the correspond-
ing alleles harbored by the MenW:ST-11 clone respon-
sible for the increase in invasive MenW disease in the 
United Kingdom (5). We examined capsular expression 
by serogrouping and found 32 (62%) of the MenW iso-
lates expressed the W capsular polysaccharide. Of the 21 
MenW carriers in March 2016 who had been vaccinated 
at least 5 months before sampling, 15 (71%) were harbor-
ing isolates expressing the W capsule (online Technical 
Appendix Table 2).
Conclusions
We detected a rapid rise in carriage of MenW among first-
year students in a university setting in the United King-
dom. In comparison, carriage of MenC in adolescents and 
young adults in the United Kingdom, including in univer-
sity students, was rare before the introduction of MenC 
monovalent conjugate vaccines (9). The rise in MenW 
carriage is most likely due to acquisition within student 
dormitories or social spaces on campus but was unexpect-
ed because no such isolates were found in a similar study 
at the UoN in 2008–09 (15), and only a limited number in 
a multicenter carriage study involving UK universities in 
2010–11 (6,10).
The increase in MenW carriage among university stu-
dents merits further monitoring because it could contrib-
ute further to the sustained increase in MenW disease in 
the United Kingdom. Two cases of MenW disease were 
reported in unvaccinated students in Nottingham during 
2015–16. Students attending universities exhibit high mo-
bility and may represent an ongoing vehicle for amplifica-
tion and spread of MenW into communities throughout the 
United Kingdom or beyond, with implications for vaccina-
tion policy and future research.
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The work of art shown here depicts the interrela-
tionship of human, animal, and environmental health.
Stained-glass windows have been appreciated 
for their utility and splendor for more than 1,000 
years, and this engaging work of art by stained glass 
artist Jenny Hammond reminds us that influenza 
A viruses—which can be easily spread between 
animals and human, use various host species, and 
exist in many different environments—remain an 
enduring and global health concern.
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